M C Benyunes
Overview
Explore the profile of M C Benyunes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wolff S, Herzig R, Lynch J, Ericson S, Greer J, Stein R, et al.
Bone Marrow Transplant
. 2001 Mar;
27(3):261-8.
PMID: 11277173
Thrombocytopenia following myelotoxic therapy is a common problem and when severe (<20,000/microl) can lead to severe morbidity and mortality. Thrombopoietin (TPO) is a naturally occurring glycosylated peptide which stimulates the...
2.
Fefer A, Robinson N, Benyunes M, Bensinger W, Press O, Thompson J, et al.
Cancer J Sci Am
. 1998 Feb;
3 Suppl 1:S48-53.
PMID: 9457394
Purpose: Autologous or allogeneic bone marrow transplantation (BMT) or stem cell transplantation (SCT) for advanced hematologic malignancies is associated with a high relapse rate. It has been postulated that recombinant...
3.
Mogul M, Forte K, Holland H, Turner C, Benyunes M, Yeager A
J Pediatr Hematol Oncol
. 1997 Mar;
19(2):142-4.
PMID: 9149745
Purpose: This study evaluated the feasibility of performing haploidentical CD34+ selected transplants for children with Down's syndrome (DS) and recurrent leukemia. Patients And Methods: Within a cohort of 15 children,...
4.
Robinson N, Benyunes M, Thompson J, York A, Petersdorf S, Press O, et al.
Bone Marrow Transplant
. 1997 Mar;
19(5):435-42.
PMID: 9052908
The success of autologous stem cell transplantation (ASCT) for hematologic malignancy is limited largely by a high relapse rate. It is postulated that IL-2 administered after ASCT may eliminate minimal...
5.
Massumoto C, Benyunes M, Sale G, Beauchamp M, York A, Thompson J, et al.
Bone Marrow Transplant
. 1996 Mar;
17(3):351-6.
PMID: 8704686
The high relapse rate of hematologic malignancy treated with autologous bone marrow transplantation (ABMT) may reflect the absence of a graft-versus-leukemia (GVL) effect usually associated with graft-versus-host disease (GVHD). The...
6.
Robinson N, Sanders J, Benyunes M, Beach K, Lindgren C, Thompson J, et al.
Blood
. 1996 Feb;
87(4):1249-54.
PMID: 8608212
Allogeneic bone marrow transplantation (BMT) for advanced acute leukemia is associated with a high risk of relapse. It is postulated that interleukin-2 (IL-2) administered after BMT might induce or amplify...
7.
Benyunes M, Higuchi C, York A, Lindgren C, Thompson J, Buckner C, et al.
Bone Marrow Transplant
. 1995 Aug;
16(2):283-8.
PMID: 7581149
Early relapse remains a major challenge after autologous bone marrow transplant for malignant lymphoma (ML). It is postulated that consolidative immunotherapy with interleukin 2 (IL-2) with or without lymphokine-activated killer...
8.
Benyunes M, Sullivan K, Deeg H, Mori M, Meyer W, Fisher L, et al.
Int J Radiat Oncol Biol Phys
. 1995 Jun;
32(3):661-70.
PMID: 7790252
Purpose: To determine the risk of, and risk factors for, developing cataracts after bone marrow transplantation. Methods And Materials: Four hundred and ninety-two adults who underwent bone marrow transplantation in...
9.
Thompson J, Bianco J, Benyunes M, Neubauer M, Slattery J, Fefer A
Cancer Res
. 1994 Jul;
54(13):3436-41.
PMID: 8012963
The dose of interleukin 2 (IL-2) which can be administered to cancer patients is limited largely by a capillary leak syndrome. Pentoxifylline (PTX) is a methylxanthine which reduces IL-2 toxicity...
10.
Neubauer M, Benyunes M, Thompson J, Bensinger W, Lindgren C, Buckner C, et al.
Bone Marrow Transplant
. 1994 Mar;
13(3):311-6.
PMID: 7911048
Immunotherapy with interleukin-2 (IL-2) early after peripheral blood stem cell transplantation (PBSCT) is being considered as a potential way to eradicate minimal residual disease. The aim of this study was...